🦁
|
Proteomic Biomarkers for the Detection of Endometrial Cancer
K. Njoku,
D. Chiasserini,
A. Whetton,
E. Crosbie
|
5 |
2019 |
5 🦁
|
🦁
|
Endometrial cancer prevention in high-risk women.
K. Njoku,
J. Abiola,
Johanna Russell,
E. Crosbie
|
5 |
2019 |
5 🦁
|
🦁
|
Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer
7 auth.
K. Njoku,
D. Chiasserini,
E. Jones,
Chloe E. Barr,
H. O’Flynn,
A. Whetton,
...
E. Crosbie
|
5 |
2020 |
5 🦁
|
🦁
|
Current and Emerging Prognostic Biomarkers in Endometrial Cancer
K. Njoku,
Chloe E. Barr,
E. Crosbie
|
5 |
2022 |
5 🦁
|
🐬
|
Detecting endometrial cancer
E. Jones,
H. O’Flynn,
K. Njoku,
E. Crosbie
|
5 |
2020 |
5 🐬
|
🦁
|
Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial Cancer
K. Njoku,
C. Sutton,
A. Whetton,
E. Crosbie
|
5 |
2020 |
5 🦁
|
🦁
|
Impact of pre-treatment prognostic nutritional index and the haemoglobin, albumin, lymphocyte and platelet (HALP) score on endometrial cancer survival: A prospective database analysis
K. Njoku,
Chloe E. Barr,
N. Ramchander,
E. Crosbie
|
4 |
2022 |
4 🦁
|
🦁
|
Pre-treatment inflammatory parameters predict survival from endometrial cancer: A prospective database analysis
K. Njoku,
N. Ramchander,
Y. Wan,
Chloe E. Barr,
E. Crosbie
|
4 |
2021 |
4 🦁
|